Dr Jasmine Ramiah unpacks why psychosocial management, pharmacological treatment, coupled with patient advocacy and compliance ensures the best outcomes for multiple myeloma.
The relatively recent ease of access to lenalidomide in South Africa has revolutionised multiple myeloma management. Dr Zeenat Moorad expands on this.
Multiple myeloma is a blood cancer that develops from a special type of white blood cell, called a plasma cell, in the bone marrow. Plasma cells are part of the immune system, and make proteins called antibodies (immunoglobulins) that attack and kill bacteria and viruses, protecting against infection.
Amanda Koch details her emotional journey of paraplegia due to multiple myeloma to the miracle of walking again and successful treatment.
Dr Garrick Laudin explains the effects of multiple myeloma on bone health and the treatments needed to preserve the bones.
You can listen to this article below, or by using your favourite podcast player at pod.link/oncologybuddies
You can listen to this articles below, or by using your favourite podcast player at pod.link/oncologybuddies
You can listen to this articles below, or by using your favourite podcast player at pod.link/oncologybuddies